Clinical Trial Update: Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating terlipressin infusion adjusted to hemodynamic response for hepatorenal syndrome in patients with cirrhosis. The current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatorenal Syndrome Type 1

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Pere Gines | Conditions: Cirrhosis, Hepatorenal Syndrome Type I | Phase 4 | Status: UNKNOWN